logo
Share SHARE
FONT-SIZE Plus   Neg

GenVec Names Cynthia Collins President, CEO - Quick Facts

GenVec, Inc. (GNVC) said it appointed Cynthia Collins as president and chief executive officer, or CEO, effective May 23, 2012. Besides, Collins is expected to be appointed to the Board of Directors of GenVec.

Effective upon Collins' appointment, Paul Fischer will step down as GenVec's president and CEO and as a member of the Board.

Collins formerly served as Group vice president, Cellular Analysis Business of Beckman Coulter from 2007 to until its sale in 2011. Before joining Beckman Coulter, she served as CEO of Sequoia Pharmaceuticals, Inc., a private biotechnology company developing antiviral drugs. Before that, she served as president of Clinical Micro Sensors, Inc., a wholly owned subsidiary of Motorola where she directed the development and commercialization of molecular diagnostic microarray products and led the eventual strategic divestiture of the division.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Bank of Nova Scotia or otherwise known as Scotiabank, Friday reported lower net profit for the third quarter, in the absence of a year-ago gain. Earnings per share, however, came in line with the Street view. Further, the company said it raised its quarterly dividend by 2 cents. Non-traditional discount and variety stores operator Big Lots Inc. (BIG) Friday reported a decline in net profit for the second quarter, while net sales grew 1.2 percent from the prior year. Comparable sales for the quarter increased 2.8 percent. Google has rejected the European Union's charges that it abused its market power and the demanded that it change the way it ranks online comparison shopping services in its search results, setting up a potentially long legal battle with the EU regulator empowered to levy billions of euros in fines
comments powered by Disqus
Follow RTT